These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29323063)

  • 1. Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis.
    Kaymaz E; Ozer E; Unverdi H; Hucumenoglu S
    Indian J Pathol Microbiol; 2017; 60(4):510-514. PubMed ID: 29323063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?
    Garbar C; Mascaux C
    Anal Quant Cytol Histol; 2011 Oct; 33(5):277-82. PubMed ID: 22611755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms.
    Qi G; Liu J; Tao S; Fan W; Zheng H; Wang M; Yang H; Liu Y; Liu H; Zhou F
    PeerJ; 2023; 11():e15675. PubMed ID: 37456895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphological characteristics of low-grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high-grade papillary urothelial carcinoma.
    Takeda K; Adeniran AJ; Levi AW; Tang H; Cai G
    Cytopathology; 2024 Nov; 35(6):724-732. PubMed ID: 38992916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
    Whisnant RE; Bastacky SI; Ohori NP
    Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC).
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    J Cancer; 2017; 8(15):2885-2891. PubMed ID: 28928878
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.
    Koyuncuer A
    Indian J Pathol Microbiol; 2013; 56(1):10-5. PubMed ID: 23924551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.
    Tuna B; Yörükoglu K; Düzcan E; Sen S; Nese N; Sarsık B; Akder A; Sayhan S; Mungan U; Kirkali Z
    Virchows Arch; 2011 Jun; 458(6):659-64. PubMed ID: 21484429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
    Kalantari MR; Ahmadnia H
    Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
    Jones TD; Cheng L
    Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression profiles of MUC1 and MUC2 mucins in urothelial tumors of bladder.
    Gonul II; Cakir A; Sozen S
    Indian J Pathol Microbiol; 2018; 61(3):350-355. PubMed ID: 30004053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOLECULAR CHARACTERISTICS OF THE HETEROGENEITY OF NON-INVASIVE PAPILLARY UROTHELIAL CARCINOMAS AND THE MARKERS OF THEIR RECURRENCE.
    Kajaia D; Kochiashvili D; Muzashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2021; (316-317):178-184. PubMed ID: 34511468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).
    Jones TD; Cheng L
    Histopathology; 2020 Oct; 77(4):525-535. PubMed ID: 32562556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases.
    Tian W; Epstein JI
    Hum Pathol; 2015 Dec; 46(12):1836-41. PubMed ID: 26391571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder.
    Roychowdhury A; Dey RK; Bandyapadhyay A; Bhattacharya P; Mitra RB; Dutta R
    J Indian Med Assoc; 2012 Jun; 110(6):393-6. PubMed ID: 23360043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of recurrence and progression of low-grade papillary urothelial carcinoma of the urinary bladder: Predicting the outcome.
    Bahmad HF; Lopez O; Moreno JCA; Lopez K; Malik F; Salami A; Nieder AM; Omarzai Y; Poppiti RJ
    Ann Diagn Pathol; 2022 Dec; 61():152030. PubMed ID: 36055007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
    Holmäng S; Andius P; Hedelin H; Wester K; Busch C; Johansson SL
    J Urol; 2001 Apr; 165(4):1124-8; discussion 1128-30. PubMed ID: 11257652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
    Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K
    Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.
    Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Navone R
    Am J Surg Pathol; 2001 Dec; 25(12):1528-33. PubMed ID: 11717543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts.
    Jones TD; Cheng L
    J Urol; 2006 Jun; 175(6):1995-2003. PubMed ID: 16697785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.